(Reuters) – Highlight of the day for the administration of US President Donald Trump on Tuesday:
Trump backs a plan by US Republican lawmakers to replace the Obamacare healthcare bill, but influential conservative groups strongly oppose it, complicating the prospects of passing the proposal in Congress.
Shares of large American biotech and pharmaceutical companies are selling after Trump says he is working on a system to cut prices in the industry.
Senate Democrats, seeking to capitalize on revelations about Trump’s campaign contacts with Russia, are urging a top Republican lawmaker to obtain the president’s tax returns as a matter of national security.
The prosecutor appointed to the No. 2 position in the Justice Department refuses to commit to appointing a special prosecutor to oversee an investigation into Russian meddling in the 2016 presidential election.
The Senate Armed Services Committee votes overwhelmingly to approve Army Lieutenant General HR McMaster as Trump’s second national security adviser, despite some concern over his handling of a sexual assault case.
The Trump administration pledges in a statement to show “great rigor” on restrictions on Iran’s nuclear activities imposed by an agreement with the major powers, but gives little indication of what that could mean for the agreement.
The United States begins deploying the first elements of its advanced missile defense system in South Korea after North Korea’s test of four ballistic missiles, the United States Pacific Command says, despite angry opposition from China.
Senate Minority Leader Chuck Schumer and 11 other Democrats say it is critical that the Trump administration uphold the new vehicle fuel efficiency rules, arguing that the highest standards are achievable.
Mexico cancels existing sugar export permits to the United States to avoid sanctions in a dispute over the pace of shipments, blaming the problem in part on vacant positions at the United States Department of Commerce, according to a document seen by Reuters.
Disclaimer: Fusion Media wishes to remind you that the data contained on this website is not necessarily accurate or in real time. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but by market makers, so the prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media assumes no responsibility for any business losses you may incur as a result of the use of this data.
Fusion Media or anyone involved with Fusion Media will not accept any responsibility for loss or damage as a result of reliance on information, including data, quotes, charts, and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading financial markets, it is one of the riskiest investment forms possible.